niacinamide has been researched along with Heart Diseases in 15 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The underlying mechanism of these adverse cardiac effects is largely unknown." | 5.51 | Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies. ( Becker, JR; Force, T; Galindo, CL; Glennon, MS; Gupte, M; Lal, H; Singh, AP; Umbarkar, P; Zhang, Q, 2019) |
| "Increasing use of targeted anticancer agents that inhibit tyrosine kinase signaling (monoclonal antibodies or tyrosine kinase inhibitors) has dramatically improved the survival of patients with malignancies." | 2.45 | Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue. ( Chen, MH, 2009) |
| " The underlying mechanism of these adverse cardiac effects is largely unknown." | 1.51 | Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies. ( Becker, JR; Force, T; Galindo, CL; Glennon, MS; Gupte, M; Lal, H; Singh, AP; Umbarkar, P; Zhang, Q, 2019) |
| " Considering the critical role of VEGF signaling in the homeostasis of the cardiovascular system, we speculated that the long-term use of axitinib and sorafenib directly influenced the initiation of aortic dissection and cardiac dysfunction." | 1.48 | Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma. ( Fujita, M; Kuroda, T; Mukai, M; Nakai, Y; Nishimura, K; Oka, T; Shioyama, W; Takada, M; Yasui, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lauritzen, KH | 1 |
| Olsen, MB | 1 |
| Ahmed, MS | 1 |
| Yang, K | 1 |
| Rinholm, JE | 1 |
| Bergersen, LH | 1 |
| Esbensen, QY | 1 |
| Sverkeli, LJ | 1 |
| Ziegler, M | 1 |
| Attramadal, H | 1 |
| Halvorsen, B | 1 |
| Aukrust, P | 1 |
| Yndestad, A | 1 |
| Stuhlmiller, TJ | 1 |
| Zawistowski, JS | 1 |
| Chen, X | 1 |
| Sciaky, N | 1 |
| Angus, SP | 1 |
| Hicks, ST | 1 |
| Parry, TL | 1 |
| Huang, W | 1 |
| Beak, JY | 1 |
| Willis, MS | 1 |
| Johnson, GL | 1 |
| Jensen, BC | 1 |
| Hamza, AA | 1 |
| Fikry, EM | 1 |
| Abdallah, W | 1 |
| Amin, A | 1 |
| Takada, M | 1 |
| Yasui, T | 1 |
| Oka, T | 1 |
| Shioyama, W | 1 |
| Kuroda, T | 1 |
| Nakai, Y | 1 |
| Nishimura, K | 1 |
| Mukai, M | 1 |
| Fujita, M | 1 |
| Singh, AP | 1 |
| Glennon, MS | 1 |
| Umbarkar, P | 1 |
| Gupte, M | 1 |
| Galindo, CL | 1 |
| Zhang, Q | 1 |
| Force, T | 2 |
| Becker, JR | 1 |
| Lal, H | 1 |
| Zheng, D | 1 |
| Zhang, Y | 1 |
| Zheng, M | 1 |
| Cao, T | 1 |
| Wang, G | 1 |
| Zhang, L | 1 |
| Ni, R | 1 |
| Brockman, J | 1 |
| Zhong, H | 1 |
| Fan, GC | 1 |
| Peng, T | 1 |
| Grieco, A | 1 |
| Lombardo, A | 1 |
| Biolato, M | 1 |
| MESSINA, R | 1 |
| Chen, MH | 1 |
| Kamada, P | 1 |
| Dudek, AZ | 1 |
| MACCARINI, PA | 1 |
| FREZZA, S | 1 |
| Krause, DS | 1 |
| Van Etten, RA | 1 |
| Abiko, Y | 1 |
| Nishimura, T | 1 |
| Sakai, K | 1 |
| Litovitz, TL | 1 |
| Mrochek, JE | 1 |
| Jolley, RL | 1 |
| Young, DS | 1 |
| Turner, WJ | 1 |
4 reviews available for niacinamide and Heart Diseases
| Article | Year |
|---|---|
Cardiac dysfunction induced by novel targeted anticancer therapy: an emerging issue.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; | 2009 |
Sorafenib therapy for metastatic renal carcinoma in patients with low cardiac ejection fraction: report of two cases and literature review.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Female; Heart Diseases; Human | 2010 |
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.
Topics: Adaptor Proteins, Signal Transducing; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Ben | 2007 |
The anecdotal antidotes.
Topics: Acetylcysteine; Adult; Aged; Animals; Antidotes; Child; Cimetidine; Female; Ferrocyanides; Folic Aci | 1984 |
11 other studies available for niacinamide and Heart Diseases
| Article | Year |
|---|---|
Instability in NAD
Topics: Animals; DNA Damage; DNA Repair; DNA, Mitochondrial; Heart; Heart Diseases; HeLa Cells; Humans; Mice | 2021 |
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Recepto
Topics: Animals; Antineoplastic Agents; Cardiotoxicity; Cells, Cultured; Dose-Response Relationship, Drug; E | 2017 |
Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Combined Modality Therapy; Diabetes Mellitus, | 2018 |
Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Aortic Dissection; Axitinib; Carcinoma, Renal Cell; Heart Diseases; H | 2018 |
Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies.
Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cells, Cul | 2019 |
Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Autophagy; Cardiotoxicity; Cells, Cultured; Cytoprotection; Disease Models, A | 2019 |
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Heart Diseases; | 2013 |
The influence of vitamin PP on the exchange of creatine and creatinine in some morbid conditions; behavior of creatine and creatinine in the heart.
Topics: Creatine; Heart Diseases; Niacinamide; Nutrition Therapy | 1948 |
[ON THE CLINICAL VALUE OF COLLATERAL TROPHO-ENZYMATIC THERAPY IN ACUTE AND CHRONIC HEART DISEASES].
Topics: Coenzymes; Coronary Disease; Heart Diseases; Humans; Hypertension; Khellin; Niacin; Niacinamide; Pul | 1964 |
Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.
Topics: Acidosis; Animals; Coronary Disease; Dogs; Female; Heart Diseases; Male; Niacinamide; Nicorandil; Va | 1984 |
Metabolic response of humans to ingestion of nicotinic acid and nicotinamide.
Topics: Adult; Alcoholism; Computers; Heart Diseases; Humans; Kinetics; Male; Middle Aged; Niacinamide; Nico | 1976 |